Alberto Hernando-Calvo,Maria Vila-Casadesús,Yacine Bareche,Alberto Gonzalez-Medina,Farnoosh Abbas-Aghababazadeh,Deborah Lo Giacco,Agatha Martin,Omar Saavedra,Irene Brana,Maria Vieito,Roberta Fasani,John Stagg,Francesco Mancuso,Benjamin Haibe-Kains,Ming Han,Roger Berche,Trevor J Pugh,Oriol Mirallas,Jose Jimenez,Nadia Saoudi Gonzalez,Claudia Valverde,Eva Muñoz-Couselo,Cristina Suarez,Marc Diez,Elena Élez,Jaume Capdevila,Ana Oaknin,Cristina Saura,Teresa Macarulla,Joan Carles Galceran,Enriqueta Felip,Rodrigo Dienstmann,Philippe L Bedard,Paolo Nuciforo,Joan Seoane,Josep Tabernero,Elena Garralda,Ana Vivancos
Alberto Hernando-Calvo
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G2C4, Canada; Departamento de Medicina, Universidad Autónoma de Barcelona (UAB), 08035 Barcelona, Spain.
Maria Vila-Casadesús
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Yacine Bareche
Institut du Cancer de Montréal, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montréal, QC H2X0A9, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, QC H3T1J4, Canada.
Alberto Gonzalez-Medina
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Farnoosh Abbas-Aghababazadeh
Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2C4, Canada.
Deborah Lo Giacco
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Agatha Martin
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Omar Saavedra
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Irene Brana
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Maria Vieito
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Roberta Fasani
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
John Stagg
Institut du Cancer de Montréal, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montréal, QC H2X0A9, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, QC H3T1J4, Canada.
Francesco Mancuso
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2C4, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G1L7, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5S2E4, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G0A3, Canada; Vector Institute for Artificial Intelligence, Toronto, ON M5G1M1, Canada.
Ming Han
Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2C4, Canada.
Roger Berche
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2C4, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G1L7, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G0A3, Canada.
Oriol Mirallas
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Jose Jimenez
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Nadia Saoudi Gonzalez
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Claudia Valverde
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Eva Muñoz-Couselo
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Cristina Suarez
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Marc Diez
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Elena Élez
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Jaume Capdevila
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Ana Oaknin
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Cristina Saura
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Teresa Macarulla
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Joan Carles Galceran
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Enriqueta Felip
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Rodrigo Dienstmann
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Philippe L Bedard
Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G2C4, Canada.
Paolo Nuciforo
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Joan Seoane
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Josep Tabernero
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Elena Garralda
Department of Medical Oncology, Vall D’Hebron University Hospital, 08035 Barcelona, Spain; Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain.
Ana Vivancos
Vall d’Hebron Institute of Oncology, 08035 Barcelona, Spain. Electronic address: avivancos@vhio.net.
